research use only

(+)-Gallocatechin Cannabinoid Receptor modulator

Cat.No.S9048

(+)-Gallocatechin, found notably in green tea, has moderate affinity to the human cannabinoid receptor and acts as an antioxidant.
(+)-Gallocatechin Cannabinoid Receptor modulator Chemical Structure

Chemical Structure

Molecular Weight: 306.27

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 306.27 Formula

C15H14O7

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 970-73-0 -- Storage of Stock Solutions

Synonyms N/A Smiles C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O

Solubility

In vitro
Batch:

DMSO : 10 mg/mL ( (32.65 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03413735 Unknown status
Obesity|Endotoxemia|Inflammation
Ohio State University
August 29 2018 Not Applicable
NCT02779361 Completed
Healthy Volunteers|Doping in Sports
Parc de Salut Mar|World Anti-Doping Agency
January 2016 Phase 1
NCT02008721 Completed
Multiple System Atrophy
Dr. Johannes Levin|German Center for Neurodegenerative Diseases (DZNE)|Deutsche Parkinson Vereinigung|German Foundation for Neurology|ParkinsonFonds Deutschland gGmbH|Ludwig-Maximilians - University of Munich
January 2014 Phase 3
NCT01923597 Completed
Diabetic Nephropathy|Hypertension
University of Campinas Brazil
November 2013 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map